Business Wire

Quickline uses ADVA 100G aggregation solution to expand ultra-fast broadband to rural and hard-to-reach communities

Share

ADVA (FSE: ADV) today announced that Quickline has deployed its FSP 150 aggregation solution to offer high-speed residential and enterprise services across the hardest-to-reach areas in Yorkshire and Lincolnshire. The innovative new network utilizes 5G wireless and FTTP for the last mile. Combined with ADVA’s MEF 3.0-certified 100Gbit/s technology, this enables Quickline to rapidly expand the delivery of ultra-fast, highly available broadband to more remote locations across the region. Temperature-hardened and simple to deploy, ADVA’s compact edge solution provides pre-activation testing and features the highly accurate synchronization capabilities vital for 5G services. ADVA’s partner, Nomios, played a key role in the deployment, planning and designing of the new infrastructure as well as providing project management, network management services and ongoing support.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220615005587/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ADVA’s edge technology is helping Quickline to rapidly deliver high-speed internet access to remote users in the UK. (Photo: Business Wire)

“Our mission is to give customers access to gigabit-capable broadband in the hardest-to-reach rural areas of the UK. To do that, we’ve harnessed the most advanced aggregation device and taken an innovative approach to last-mile connectivity. By leveraging the flexibility and power of ADVA’s FSP 150 to link our 5G-based services to PoPs, we can deliver lightning-fast broadband to more rural communities than ever before,” said Sean Royce, CEO of Quickline. ”Working with trusted and proven partners such as ADVA and Nomios with their strong customer-first ethos was also important to us in our decision making.”

Supported by the Building Digital UK program, Quickline’s expanded network is helping to connect some of Britain’s hardest-to-reach places. Built on the high-density ADVA FSP 150-XG400 Series, the infrastructure enables 100Gbit/s connectivity in the national network as well as the distribution of the highly precise phase and frequency synchronization needed for 5G. For smaller nodes, Quickline has also deployed the FSP 150-XG100Pro Series. Both solutions bring together a rich set of programmability and security features contained within a compact and environmentally hardened case. What’s more, with 24/7 monitoring from Nomios, any faults can be proactively identified and rectified with minimal impact on end users.

“We’re pleased to be supporting Quickline with its goal of offering high-speed internet to those living and working in underserved areas. With more people than ever working from home, it’s vital to close the digital divide and ensure that families and businesses can benefit from the same high-quality services as those in urban areas,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “Our FSP 150 family of carrier-class packet devices is the perfect fit for Quickline’s expanding network. Designed to deliver high-density transport, aggregation and demarcation of 5G and MEF 3.0 CE services, our solutions ensure fast and reliable fixed-line or wireless connectivity. We’re looking forward to helping Quickline continue to grow with support from us and our partner Nomios.”

“Homes and businesses now expect and depend on fast, reliable broadband. That’s why Quickline is harnessing our expertise with ADVA’s packet edge technology to build a new high-speed residential and enterprise network. The opportunity for strategic growth is now firmly in place with the ability to scale services at the edge and extend reach to customers in hard-to-reach locations. This has been achieved in a highly reliable, time- and cost-efficient way,” said Richard Butcher, MD of UK&I at Nomios. “With our monitoring service, ongoing management, maintenance and training, Quickline is well prepared for the future. Working together, Nomios and ADVA helped Quickline to combine their 5G technologies and best-of-breed access solutions, creating an extremely innovative and efficient network architecture that will deliver on present day and future customer expectations across Yorkshire, Lincolnshire and beyond.”

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

About Nomios

Nomios are a cyber security and networking solutions provider for global enterprises, telecommunications operators and service providers. They combine technologies, processes and the best human expertise to create next generation services and solutions. Their service quality and operational excellence results in the highest customer satisfaction in the market. www.nomios.co.uk.

About Quickline

Quickline is focussed on delivering improved broadband connectivity in rural areas of the north of England and beyond where a significant digital divide remains and many hundreds of thousands of premises are in desperate need of increased broadband speeds. The East Yorkshire-based firm is an innovative forward-thinking Internet Service Provider (ISP) with its heritage in fixed wireless, but its network includes increasing amounts of full fibre connectivity, as well as rural-delivered 5G technology. Its aim is to be the leading UK-dedicated, rural broadband infrastructure provider, delivering innovative, flexible and hybrid solutions that can address the millions of premises ignored by previous commercial rollouts for many years to come. They believe in ultrafast internet for all, no matter where you live or work. www.quickline.co.uk.

Published by:

ADVA Optical Networking SE, Munich, Germany

www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye